Your browser doesn't support javascript.
loading
Xpert MTB/RIF assay in the diagnosis of pulmonary tuberculosis in children in tertiary care setting in South India.
Velayutham, Banurekha; Hissar, Syed; Thiruvengadam, Kannan; Narayan Sivaramakrishnan, Gomathi; Subramanyam, Balaji; Navaneethapandian, Pooranagangadevi; Reddy, Devarajulu; Nair, Dina; Kannabiran, Bhavani; Balaji, Sarath; Selladurai, Elilarasi; Ganesh, Jayachandran; Aravind, Malayappan Ayyavu; Rathinam, Prabhakaran; Chellaiah, Luke Ravi; Rose, Winsley; Luke Elizabeth, Hannah; Sakaya, Annie; Joseph, Bency; Sundaralingam, Vennila; Karthikeyan, Sananthya; Dhanaraj, Baskaran; Natrajan, Mohan; Swaminathan, Soumya.
Afiliação
  • Velayutham B; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Hissar S; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Thiruvengadam K; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Narayan Sivaramakrishnan G; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Subramanyam B; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Navaneethapandian P; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Reddy D; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Nair D; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Kannabiran B; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Balaji S; Department of Paediatric Pulmonology, Institute of Child Health and Hospital for Children, Chennai, Tamil Nadu-600008, India.
  • Selladurai E; Department of Paediatric Pulmonology, Institute of Child Health and Hospital for Children, Chennai, Tamil Nadu-600008, India.
  • Ganesh J; Department of Paediatrics, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu-600001, India.
  • Aravind MA; Department of Paediatrics, Government Stanley Medical College and Hospital, Chennai, Tamil Nadu-600001, India.
  • Rathinam P; Department of Respiratory Medicine, Government Rajaji Hospital, Madurai, Tamil Nadu-625020, India.
  • Chellaiah LR; Department of Paediatrics, Government Vellore Medical College Hospital, Vellore, Tamil Nadu-632011, India.
  • Rose W; Department of Paediatrics, Christian Medical College Hospital, Vellore, Tamil Nadu-632002, India.
  • Luke Elizabeth H; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Sakaya A; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Joseph B; Indian Council of Medical Research, National Centre for Disease Informatics and Research, Bengaluru, Karnataka-562110, India.
  • Sundaralingam V; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Karthikeyan S; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Dhanaraj B; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Natrajan M; Indian Council of Medical Research, National Institute for Research in Tuberculosis, Chennai, Tamil Nadu-600031, India.
  • Swaminathan S; Chairperson, M S Swaminathan Research Foundation (MSSRF), Chennai, Tamil Nadu-600113, India.
J Trop Pediatr ; 70(5)2024 Aug 10.
Article em En | MEDLINE | ID: mdl-39152039
ABSTRACT
Xpert MTB/RIF is recommended for the diagnosis of tuberculosis (TB) in children. We determined the performance of Xpert MTB/RIF in the diagnosis of pulmonary TB in children. The characteristics of children influencing Xpert MTB/RIF positivity were explored. Children aged <15 years with symptoms suggestive of pulmonary TB were prospectively enrolled from 2013 to 2019. Two sputum/early morning gastric aspirate specimens were collected for examination by smear (fluorescence microscopy), Xpert MTB/RIF, and culture [Mycobacteria growth indicator tube (MGIT)/Lowenstein-Jensen (LJ) medium]. Diagnostic performance of Xpert MTB/RIF was evaluated using LJ and or MGIT culture positivity as the reference standard. Sensitivity, specificity with 95% confidence interval (CI) were calculated. Stratified analysis was done; P < .05 was considered statistically significant. Of the total 1727 enrolled children, 1674 (97%) with complete results for at least one sputum/gastric aspirate sample were analyzed. The sensitivity of Xpert MTB/RIF was 68.5% in sputum and 53.6% in gastric aspirate while the specificity was 99% for both. The sensitivity compared to smear was 68.5% vs. 33.7% (P < .001) and 53.6% vs. 14.5%; (P < .001) in sputum and gastric aspirate, respectively. The sensitivity of Xpert MTB/RIF was 23.9% with decision to treat as reference standard. Xpert MTB/RIF positivity was significantly influenced by sex, age, nutritional status, chest X-ray abnormality, TB infection status, and symptoms suggestive of TB. Xpert MTB/RIF as an upfront test compared to smear improves diagnosis of pulmonary TB in children yet the sensitivity is suboptimal. Newer TB diagnostic tools with improved sensitivity is warranted in children.
We evaluated the performance of Xpert MTB/RIF in the diagnosis of pulmonary TB in children and explored the characteristics influencing Xpert MTB/RIF positivity. Sputum and or early morning gastric aspirate specimen was collected from children aged <15 years with symptoms suggestive of pulmonary TB. This was examined by smear (fluorescence microscopy), Xpert MTB/RIF, and culture (Mycobacteria growth indicator tube (MGIT)/Lowenstein­Jensen (LJ) medium). Diagnostic performance of Xpert MTB/RIF was evaluated using LJ and or MGIT culture positivity as the reference standard. Of the total 1727 enrolled children, 1674 (97%) with complete results for at least one sputum/gastric aspirate sample were analyzed. The sensitivity of Xpert MTB/RIF was 68.5% in sputum and 53.6% in gastric aspirate which was higher than smear and the specificity was 99%. The sensitivity of Xpert MTB/RIF was 23.9% with decision to treat for TB as reference standard. The Xpert MTB/RIF positivity was influenced by sex, age, nutritional status, chest X-ray abnormality, TB infection status, and symptoms suggestive of TB. Xpert MTB/RIF as an upfront test compared to smear improves the diagnosis of pulmonary TB in children yet the sensitivity is suboptimal. Newer TB diagnostic tools with improved sensitivity is warranted in children.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escarro / Tuberculose Pulmonar / Atenção Terciária à Saúde / Sensibilidade e Especificidade / Mycobacterium tuberculosis Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Escarro / Tuberculose Pulmonar / Atenção Terciária à Saúde / Sensibilidade e Especificidade / Mycobacterium tuberculosis Limite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male País como assunto: Asia Idioma: En Ano de publicação: 2024 Tipo de documento: Article